Ivana Vancurova

Title: Innovations in Cancer Treatment by Ivana Vancurova

Introduction

Ivana Vancurova is a notable inventor based in New Hyde Park, NY (US). She has made significant contributions to the field of cancer treatment, particularly in addressing solid tumor cancers. Her innovative approach focuses on utilizing a combination of specific inhibitors to enhance therapeutic outcomes for patients.

Latest Patents

Ivana Vancurova holds a patent for "Methods for treating solid tumor cancers using a histone deacetylase inhibitor and an IκB kinase inhibitor." This patent outlines a method for treating solid tumor cancers, specifically targeting ovarian cancer and drug-resistant solid tumors. The method involves administering a combination therapy that includes a therapeutically effective amount of an HDAC inhibitor and an IKK inhibitor to a subject in need. Additionally, the patent describes pharmaceutical compositions and kits that incorporate these inhibitors.

Career Highlights

Ivana Vancurova is affiliated with St. John's University, where she continues her research and development in cancer therapies. Her work is characterized by a commitment to improving treatment options for patients suffering from challenging forms of cancer.

Collaborations

Ivana has collaborated with notable colleagues, including Himavanth R Gatla and Bipradeb Singha. These collaborations have contributed to the advancement of her research and the development of innovative treatment methods.

Conclusion

Ivana Vancurova's contributions to cancer treatment through her patented methods highlight her dedication to improving patient outcomes. Her innovative work in utilizing combination therapies represents a significant advancement in the fight against solid tumor cancers.